rheumatology
Medicines

Call for consensus on HCQ retinopathy screening

Australia should develop local screening guidelines for hydroxychloroquine retinopathy given the number of rheumatology patients using the DMARD long term and at risk of permanent vision loss. A Perspective article in the MJA said thousands of Australians were potentially at risk given a 7.5% prevalence rate of retinopathy in patients who had taken hydroxychloroquine (HCQ) ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic